Abstract
Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2) are suggested to be caused by the same metabolic disorder. Defects in gut hormone-dependent regulation of beta-cell function (entero-insular axis) have been proposed to contribute to the pathogenesis of DM2. The aim of study was to evaluate whether an impaired secretion of glucagon-like peptide-1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP) could play a role in the development of carbohydrate disorders during pregnancy.
| Original language | English |
|---|---|
| Journal | Gynecological Endocrinology |
| Volume | 23 |
| Issue number | 1 |
| Pages (from-to) | 58-62 |
| Number of pages | 5 |
| ISSN | 0951-3590 |
| Publication status | Published - 1 Jan 2007 |
Fingerprint
Dive into the research topics of 'Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS